Dr. Lucy Ochola

Chairperson | Clinical Pharmacist & AMS Leader

Dr. Lucy A. Ochola is a Clinical Pharmacist, researcher, and Antimicrobial Stewardship (AMS) expert with over ten years of experience advancing evidence-based interventions to combat antimicrobial resistance (AMR) in low- and middle-income country (LMIC) settings. She holds a Master’s degree in Clinical Pharmacy from the University of Nairobi and is a recipient of the ESCMID AMS award.

She has led the design, implementation, and scale-up of antimicrobial stewardship (AMS), infection prevention and control (IPC), and quality improvement (QI) programmes within tertiary healthcare facilities in Kenya. Notably, she spearheaded the establishment of the first hospital-based AMS programme in Machakos County, overseeing antimicrobial use (AMU) surveillance, antimicrobial consumption monitoring, and diagnostic stewardship initiatives.

---

Role

In her role as Chairperson and Human Health Specialist, she provides technical leadership in AMS, IPC, and quality improvement, supporting the integration of evidence-based interventions into health systems. Her work strengthens antimicrobial use, diagnostics utilisation, and patient safety through stewardship governance, surveillance-informed decision-making, and multidisciplinary capacity building.

---

Innovation

Dr. Ochola applies implementation science and behaviour change approaches to embed AMS, IPC, diagnostics stewardship, and quality improvement into routine clinical care. She leverages data-driven feedback loops, mentorship models, and digital learning platforms to ensure sustainable impact and continuous system improvement.

---

Policy Contribution

At the national level, she serves as a trainer, technical expert, and contributor to AMR and AMS programmes supported by the Ministry of Health Kenya and international partners. She contributes to the development of national AMS and IPC guidelines, surveillance frameworks, and policy processes aligned with national action plans, regional priorities, and global AMR strategies.